Showing 9351-9360 of 20377 results for "".
- Personalized Vaccine for Liver Cancer Shows Promise in Clinical Trialhttps://reachmd.com/news/personalized-vaccine-for-liver-cancer-shows-promise-in-clinical-trial/2467322/Adding a personalized anti-tumor vaccine to standard immunotherapy is safe and about twice as likely to shrink cancer as standard immunotherapy alone for patients with hepatocellular carcinoma, the most common type of liver cancer, according to a clinical trial
- Experts Advocate for Fair Transplant Opportunities at Centershttps://reachmd.com/news/experts-advocate-for-fair-transplant-opportunities-at-centers/2463084/INDIANAPOLIS – An Expert Insight, published in the journal Transplantation, highlights health equity, disparity and inequality in organ transplantation along the continuum of care and across organ types. The authors provide a guide to transplant centers for the use of disparity-sen
- New Resource for Selecting Best Treatment Path for Young Children with Cancerous Tumors Published by NCCNhttps://reachmd.com/news/new-resource-for-selecting-best-treatment-path-for-young-children-with-cancerous-tumors-published-by-nccn/2457082/New NCCN Guidelines for Neuroblastoma address the importance and impact of risk stratification for treating one of the more common types of pediatric solid tumors; includes vanguard treatment recommendations involving multimodality treatment for high-risk disease.
- Can Genetics Affect the Need for Surgery in Patients with Thumb Osteoarthritis?https://reachmd.com/news/can-genetics-affect-the-need-for-surgery-in-patients-with-thumb-osteoarthritis/2456966/Rhizarthrosis, also known as trapeziometacarpal osteoarthritis, is a type of osteoarthritis that affects the thumb, and treatments range from splints to surgery. Investigators have uncovered various genetic differences between individuals with rhizarthrosis who undergo surgery for their condition
- Analysis of HPV-Positive Cells Reveals New Population Found in Cancerhttps://reachmd.com/news/analysis-of-hpv-positive-cells-reveals-new-population-found-in-cancer/2456732/Experts at Cincinnati Children’s using single-cell sequencing technology discovered a HIDDEN compartment of cells in HPV-infected tissues present in several types of cancer Persistent infection with human papillomavirus (HPV
- NCI Launches Cancer Screening Research Networkhttps://reachmd.com/news/nci-launches-cancer-screening-research-network/2463153/The Cancer Screening Research Network will evaluate emerging technologies for cancer screening, such as blood tests that can screen for several types of c
- NRTIs and Ocular Risks: Uncovering the Link to Glaucomahttps://reachmd.com/news/nrtis-and-ocular-risks-uncovering-the-link-to-glaucoma/2475579/Nucleoside and nucleotide reverse transcriptase inhibitors, central to HIV management, are now linked to unexpected ocular risks—unpacking the connections and concerns for ocular health in patients undergoing antiretroviral therapy. As the backbone of modern HIV regimens, NRTIs have transf
- COVID-19 Masks Rising Homicide Toll on Black Menhttps://reachmd.com/news/covid-19-masks-rising-homicide-toll-on-black-men/2467914/While the COVID-19 pandemic quickly reversed decades of progress in closing the gap between life expectancies for Black and white people in the United States, the disease's toll may have obscured the impact of another significant public health con
- Post-Pandemic US Cardiovascular Death Rate on Risehttps://reachmd.com/news/post-pandemic-us-cardiovascular-death-rate-on-rise/2456943/Ann Arbor, January 24, 2024 – New research confirms what public health leaders have been fearing: the significant uptick in the cardiovascular disease (CVD) death rate that began in 2020 has continued. The continuing trend reverses improvements achieved in the decade before the COV
- STRIDE-13 Finds V116 Immunogenic in At-Risk Children and Adolescentshttps://reachmd.com/news/stride-13-finds-v116-immunogenic-in-at-risk-children-and-adolescents/2487779/Key Takeaways V116 was associated with noninferior responses for serotypes shared with PPSV23 and stronger responses for serotypes unique to V116. The study enrolled previously vaccinated children and adolescents aged 2 to <18 years with diabetes me